Information about several papers discussed during the fourth international meeting of the Association for Immunotherapy of Cancer held in Germany is presented. Newly discovered tumor-associated antigens for antibody and T-cell based therapies were delivered and demonstrated. Various approaches and techniques targeting candidate antigens in immunotherapy were also discussed.